
Israel’s Teva Lifts Outlook With War Not Curbing Drug Production
Teva Pharmaceutical Industries Ltd., one of Israel’s largest companies, increased its revenue guidance for the second straight quarter,
2023-11-08 20:52

Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:17

Gilead Recovers as Quarterly Revenue Reassures Investors
Gilead Sciences Inc. shares erased a decline as a strong quarterly performance more than offset a lower profit
2023-08-04 05:20

Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:30

Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
2023-07-06 15:50

Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify
Teva Pharmaceutical Industries Ltd. plans to cut back manufacturing of generic drugs, citing low profitability, at a time
2023-05-19 05:17

White House Assembles Secret Team to Tackle Drug Shortages, Quality Woes
As US drug shortages hit a five-year high and concerns mount about the safety of medicines, the Biden
2023-05-11 01:47